GB1455997A - M-dioxane-5-methylamine analgesics - Google Patents

M-dioxane-5-methylamine analgesics

Info

Publication number
GB1455997A
GB1455997A GB5711373A GB5711373A GB1455997A GB 1455997 A GB1455997 A GB 1455997A GB 5711373 A GB5711373 A GB 5711373A GB 5711373 A GB5711373 A GB 5711373A GB 1455997 A GB1455997 A GB 1455997A
Authority
GB
United Kingdom
Prior art keywords
formula
image
analgesics
methylamine
dioxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5711373A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1455997A publication Critical patent/GB1455997A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB5711373A 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics Expired GB1455997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
GB1455997A true GB1455997A (en) 1976-11-17

Family

ID=23214841

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2900376A Expired GB1455998A (en) 1972-12-08 1973-12-10 2-alpha-substituted-amino-benzyl-1,3-propane-diols
GB5711373A Expired GB1455997A (en) 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB2900376A Expired GB1455998A (en) 1972-12-08 1973-12-10 2-alpha-substituted-amino-benzyl-1,3-propane-diols

Country Status (27)

Country Link
JP (2) JPS5742633B2 (US06653308-20031125-C00199.png)
AR (3) AR206306A1 (US06653308-20031125-C00199.png)
AT (2) AT330773B (US06653308-20031125-C00199.png)
BE (1) BE808340A (US06653308-20031125-C00199.png)
BG (4) BG22386A3 (US06653308-20031125-C00199.png)
CA (2) CA1014560A (US06653308-20031125-C00199.png)
CH (4) CH605903A5 (US06653308-20031125-C00199.png)
CS (3) CS222209B2 (US06653308-20031125-C00199.png)
CY (1) CY1017A (US06653308-20031125-C00199.png)
DD (3) DD110864A5 (US06653308-20031125-C00199.png)
DE (1) DE2361340C2 (US06653308-20031125-C00199.png)
DK (1) DK134717B (US06653308-20031125-C00199.png)
ES (4) ES421290A1 (US06653308-20031125-C00199.png)
FR (1) FR2209578B1 (US06653308-20031125-C00199.png)
GB (2) GB1455998A (US06653308-20031125-C00199.png)
HK (1) HK60479A (US06653308-20031125-C00199.png)
HU (2) HU168763B (US06653308-20031125-C00199.png)
IE (1) IE40226B1 (US06653308-20031125-C00199.png)
IL (1) IL43773A (US06653308-20031125-C00199.png)
KE (1) KE2976A (US06653308-20031125-C00199.png)
MY (1) MY8000064A (US06653308-20031125-C00199.png)
NL (1) NL7316839A (US06653308-20031125-C00199.png)
PH (2) PH15197A (US06653308-20031125-C00199.png)
SE (3) SE403377B (US06653308-20031125-C00199.png)
SU (4) SU578001A3 (US06653308-20031125-C00199.png)
YU (3) YU36171B (US06653308-20031125-C00199.png)
ZA (1) ZA739207B (US06653308-20031125-C00199.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (en) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
ES444911A1 (es) 1977-09-01
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
NL7316839A (US06653308-20031125-C00199.png) 1974-06-11
CA1014560A (en) 1977-07-26
DD109625A5 (US06653308-20031125-C00199.png) 1974-11-12
SE7701795L (sv) 1977-02-17
ES421291A1 (es) 1976-07-01
ES421290A1 (es) 1976-07-01
YU318473A (en) 1980-09-25
SE403377B (sv) 1978-08-14
IL43773A (en) 1979-05-31
HU168763B (US06653308-20031125-C00199.png) 1976-07-28
SE7701796L (sv) 1977-02-17
HU168620B (US06653308-20031125-C00199.png) 1976-06-28
CS222209B2 (en) 1983-05-27
IE40226L (en) 1974-06-08
AU6321773A (en) 1975-06-05
FR2209578B1 (US06653308-20031125-C00199.png) 1977-09-02
DE2361340C2 (de) 1983-11-24
JPS5734835B2 (US06653308-20031125-C00199.png) 1982-07-26
ES444716A1 (es) 1977-05-16
DK134717C (US06653308-20031125-C00199.png) 1977-05-31
DD115653A5 (US06653308-20031125-C00199.png) 1975-10-12
GB1455998A (en) 1976-11-17
CS222208B2 (en) 1983-05-27
CH619219A5 (en) 1980-09-15
AR212416A1 (es) 1978-07-14
YU318573A (en) 1981-06-30
DD110864A5 (US06653308-20031125-C00199.png) 1975-01-12
ATA1026173A (de) 1976-01-15
SU587861A3 (ru) 1978-01-05
CH605903A5 (US06653308-20031125-C00199.png) 1978-10-13
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
BG26205A4 (bg) 1979-02-15
CY1017A (en) 1979-11-23
AR206306A1 (es) 1976-07-15
SU663305A3 (ru) 1979-05-15
HK60479A (en) 1979-08-31
ATA1026073A (de) 1975-10-15
BG21409A3 (bg) 1976-05-20
JPS4987680A (US06653308-20031125-C00199.png) 1974-08-22
IL43773A0 (en) 1974-03-14
CA1024150A (en) 1978-01-10
CH614439A5 (en) 1979-11-30
CS193480B2 (en) 1979-10-31
DK134717B (da) 1977-01-03
MY8000064A (en) 1980-12-31
YU36171B (en) 1982-02-25
BE808340A (fr) 1974-06-07
JPS4987681A (US06653308-20031125-C00199.png) 1974-08-22
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
SE428378B (sv) 1983-06-27
AT330773B (de) 1976-07-26
IE40226B1 (en) 1979-04-11
YU109380A (en) 1981-04-30
BG21223A3 (bg) 1976-03-20
SE417196B (sv) 1981-03-02
AT332396B (de) 1976-09-27
KE2976A (en) 1979-07-20
SU578001A3 (ru) 1977-10-25
BG22386A3 (bg) 1977-02-20
PH14923A (en) 1982-01-29
JPS5742633B2 (US06653308-20031125-C00199.png) 1982-09-09
FR2209578A1 (US06653308-20031125-C00199.png) 1974-07-05
AR212012A1 (es) 1978-04-28
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
ES413639A1 (es) Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.
ES459283A1 (es) Procedimiento para preparar 1,1-1-triaril-alquilaminas.
GB1455997A (en) M-dioxane-5-methylamine analgesics
ES424851A1 (es) Un procedimiento para preparar derivados de piperazina.
ZA912949B (en) Process for the preparation of 1-(2,3,4-trimethoxybenzyl)piperazine by reductive amination
ES8302733A1 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
GB1494823A (en) Process for the production of 2-aryl-2h-benzotriazoles
ES447664A1 (es) Procedimiento de preparacion de derivados de cardenolidas.
BE826253A (fr) Procede de preparation d'hydrogene
ES414956A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
JPS5655382A (en) Manufacture of ciss2*66dimethylmorpholine
ES458812A1 (es) Un procedimiento para la preparacion de 9-hidroxihexahidro- benzo (c) quinoleinas.
GB1387512A (en) Method for the preparation of hydrogen peroxide
GB1436377A (en) Isoquinoline derivatives
CH612671A5 (en) Process for producing new ethers
CH609049A5 (en) Process for the preparation of 2-aminoimidazoles
ES455870A1 (es) Procedimiento de obtencion de nuevas propilendiaminas.
ES409555A1 (es) Un procedimiento para la obtencion de nuevos derivados de cefalosporina.
FR2318149B1 (US06653308-20031125-C00199.png)
ES392785A1 (es) Procedimiento para la preparacion de l - piroglutamil-l- histidil-l- prolinamida.
CH612907A5 (en) Process for the preparation of a new 1-aryloxy-4-amino-2-butanol
ES428011A1 (es) Procedimiento para la preparacion de 2-amino-3,5-dibromo- bencilamina.
GB1536685A (en) Process for the preparation of 1,1-dihalo-1,3-dienes
SE7412036L (US06653308-20031125-C00199.png)
ES432699A2 (es) Procedimiento para la preparacion de nuevas bencilaminas

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SPA Amended specification published
PCNP Patent ceased through non-payment of renewal fee